Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance
NCT02146937Phase 2Withdrawn
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bicalutamide, finasteride in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Planned start Mar 2014; status: withdrawn.
02
Drugs
bicalutamidefinasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02146937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02146937.